BioSpace News Archive

This year has been a strong one for biotech initial public offerings (IPO). According to the Wall Street Journal, as of mid-October, 55 biotech companies had raised $5.75 billion.

Biopharma companies set to release financial reports next week have reported positive news in recent months.

CuraSen Therapeutics, Inc. today announced that it has appointed Gabriel Vargas, MD, PhD, as chief medical officer. Dr. Vargas brings to CuraSen more than 12 years of experience in early drug development and neuroscience expertise.

Senhwa Biosciences Inc. announced today that FDA has approved its IND application for basal cell carcinoma (BCC).

US$7m private placement to Allan Gray at an issue price of US$0.11 per CDI

On September 27, Beijing United Family Hospital (BJU) was visited by cn-healthcare.com for an interview with Prof. Zhu Gang, chief urologist and head of the department of surgery, following his completion of a difficult and high-risk surgical operation two weeks ago.

POLYTECH Health & Aesthetics GmbH, an international leader in Breast Aesthetics, announced today the launch of the new POLYTECH company branding and a new company website.

West Pharmaceutical Services, Inc. today announced that its Management Team will present an overview of the Company’s business at two investor conferences in November. Management will present at the Stephens Investment Conference in New York, New York on Wednesday, November 7, 2018, and the Jefferies 2018 London Healthcare Conference in London, United Kingdom on Thursday, November 15, 2018.

GAAP EPS from Continuing Operations of $0.21; Adj. EPS Increases 35% to $0.74

Teleflex Incorporated announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock.